[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343682-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343682-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","il-32-induced-autophagy-through-suppression-of-met-and-mtor-pathways-in-liver-tumor-growth-inhibition","IL-32γ Induced Autophagy Through Suppression of MET and mTOR Pathways in Liver Tumor Growth Inhibition","","Interleukin-32γ (IL-32γ) is examined for its role in autophagy induction in liver cancer cells and the mechanisms driving tumor growth inhibition. IL-32γ overexpression suppresses proliferation, cell-cycle progression, and migration of HepG2 and Hep3B cells while altering autophagy markers. LC3 puncta, LC3 and LAMP1 levels, and LC3–LAMP1 colocalization increase, whereas MET and mTOR pathway proteins decrease, with enhanced effects under cabozantinib plus IL-32γ. In vivo and patient samples show reduced autophagy pathway signaling and serum/tissue correlations between LC3 and IL-32γ. Overall, IL-32γ activates autophagy via MET/mTOR suppression to inhibit liver tumor growth.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/il-32-induced-autophagy-through-suppression-of-met-and-mtor-pathways-in-liver-tumor-growth-inhibition/343682/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/il-32-induced-autophagy-through-suppression-of-met-and-mtor-pathways-in-liver-tumor-growth-inhibition/343682.png","ImageObject",300,407,{"name":42,"@type":43},"Skyler","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does IL-32γ affect autophagy in liver cancer cells?","Question",{"text":63,"@type":64},"IL-32γ overexpression induces autophagy, evidenced by increased LC3 puncta, LC3 expression, and autophagy-related markers, along with higher LAMP1 and LC3–LAMP1 colocalization.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which pathways are suppressed by IL-32γ to inhibit liver tumor growth?",{"text":68,"@type":64},"IL-32γ reduces MET expression and downregulates mTOR and mTOR-related proteins, linking IL-32γ-driven autophagy induction to suppression of MET/mTOR signaling crucial for tumor growth.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the effect of combining MET inhibition with IL-32γ overexpression?",{"text":72,"@type":64},"Cabozantinib plus IL-32γ further increases LC3 puncta, LC3–LAMP1 colocalization, and the expression of autophagy-related proteins compared with IL-32γ effects alone.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343682,1790165150,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":118,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nIL-32γ Induced Autophagy Through Suppression of MET and mTOR Pathways in Liver Tumor Growth Inhibition  \nJi-Won Seo 1,†, Yong-Sun Lee 2,†, In-Sook Jeon 1, Ji-Eun Yu 3,4, Jun-Sang Yoo 1, Ja-Keun Koo 1, Dong-Ju Son 1, Jae-Suk Yoon 1, Sang-Bae Han 1, Do-Young Yoon 5, Yoon-Seok Roh 1, Jin-Tae Hong 1, *  \nand Jung-Hyun Shim 3,4, *  \nCitation: Seo, J.-W.; Lee, Y.-S.; Jeon, I.-S.; Yu, J.-E.; Yoo, J.-S.; Koo, J.-K.; Son, D.-J.; Yoon, J.-S.; Han, S.-B.; Yoon, D.-Y.; et al. IL-32γ Induced Autophagy Through Suppression of MET and mTOR Pathways in Liver Tumor Growth Inhibition. Int. J. Mol. Sci. 2024, 25, 11678. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms252111678](10.3390/ijms252111678)  \nAcademic Editor: Carlos Palmeira  \nReceived: 29 September 2024  \nRevised: 18 October 2024  \nAccepted: 28 October 2024  \nPublished: 30 October 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 College of Pharmacy and Medical Research Center, Chungbuk National University, 194-31, Osongsaengmyeong 1-ro, Osong-eup, Cheongju-si 28160, Chungbuk, Republic of Korea; [never1858@naver.com](never1858@naver.com) (J.-W.S.); [isjeon@chungbuk.ac.kr](isjeon@chungbuk.ac.kr) (I.-S.J.); [dbwnstkd8482@naver.com](dbwnstkd8482@naver.com) (J.-S.Y.); [pheej1@naver.com](pheej1@naver.com) (J.-K.K.); [sondj1@chungbuk.ac.kr](sondj1@chungbuk.ac.kr) (D.-J.S.); [jyun@chungbuk.ac.kr](jyun@chungbuk.ac.kr) (J.-S.Y.); [shan@chungbuk.ac.kr](shan@chungbuk.ac.kr) (S.-B.H.); [ysroh@chungbuk.ac.kr](ysroh@chungbuk.ac.kr) (Y.-S.R.)  \n2 Ministry of Food and Drug Safety, 187, Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu,  \nCheongju 28159, Chungbuk, Republic of Korea; [kallintz123@korea.kr](kallintz123@korea.kr)  \n3 College of Pharmacy, Mokpo National University, Muan 58554, Jeonnam, Republic of Korea; [jieunyu@mnu.ac.kr](jieunyu@mnu.ac.kr)  \n4 Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Muan 58554, Jeonnam, Republic of Korea  \n5 Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Republic of Korea; [ydy4218@konkuk.ac.kr](ydy4218@konkuk.ac.kr)  \n* [Correspondence: jinthong@chungbuk.ac.kr](Correspondence: jinthong@chungbuk.ac.kr) (J.-T.H.); [s1004jh@mokpo.ac.kr](s1004jh@mokpo.ac.kr) (J.-H.S.)† These authors contributed equally to this work.  \nAbstract: Interleukin-32γ (IL-32γ) has diverse functions in various malignancies. In this study, we investigated the role of IL-32γ in autophagy induction in liver cancer cells and delineated the underlying mechanisms. We found that the increased IL-32γ expression inhibited the growth, cell cycle progression, and migration of HepG2 and Hep3B cell lines; it also decreased the expression of related proteins. Furthermore, the IL-32γ overexpression induced autophagy, as indicated by the number of puncta, the expression of LC3, and the expression of autophagy-related markers. The expression levels of LAMP1, a protein essential for autophagosome formation, and colocalization with LC3 also increased. Big data analysis revealed that the expression of MET, a well-known target of autophagy, and the expression of mTOR and mTOR-related proteins were decreased by the IL- 32γ overexpression. The combination treatment of MET inhibitor, cabozantinib (2 µM), and IL-32γ overexpression further increased the number of puncta, the colocalization of LC3 and LAMP1, and the expression of autophagy-related proteins. In vivo, liver tumor growth was suppressed in the IL-32γ-overexpressing mouse model, and autophagy induction was confirmed by the increased expression of LC3 and LAMP1 and the decreased expression","cbCaifp8JMIhimyW","https://ap.wps.com/l/cbCaifp8JMIhimyW","pdf",6543430,"English","# Abstract\n# Introduction","[{\"question\":\"How does IL-32γ affect autophagy in liver cancer cells?\",\"answer\":\"IL-32γ overexpression induces autophagy, evidenced by increased LC3 puncta, LC3 expression, and autophagy-related markers, along with higher LAMP1 and LC3–LAMP1 colocalization.\"},{\"question\":\"Which pathways are suppressed by IL-32γ to inhibit liver tumor growth?\",\"answer\":\"IL-32γ reduces MET expression and downregulates mTOR and mTOR-related proteins, linking IL-32γ-driven autophagy induction to suppression of MET/mTOR signaling crucial for tumor growth.\"},{\"question\":\"What is the effect of combining MET inhibition with IL-32γ overexpression?\",\"answer\":\"Cabozantinib plus IL-32γ further increases LC3 puncta, LC3–LAMP1 colocalization, and the expression of autophagy-related proteins compared with IL-32γ effects alone.\"}]","IL-32γ Induced Autophagy Through Suppression of MET and mTOR Pathways in Liver Tumor Growth Inhibition | PDF",1790051789,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f79f9589d579fcc68fa855e100d1f14.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0c6ffeb4e8b66488f610851aa052208.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac5edbfcf71f1df9a3a54ead0420079d.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/416098a428ec30fcc977d37e17b1a0b3.webp",980,1385]